The PI3K/AKT/mTOR pathway is frequently activated in breast cancer brain metastases due to PTEN loss of function and frequent PIK3CA, AKT and mTOR activating mutation, as evidenced in our meta-analysis. This evidence concerns the gene PIK3CG and breast carcinoma.